| [1] |
Zou XN, Lin DM, Wan X, et al. Histological subtypes of lung cancer in Chinese males from 2000 to 2012[J]. Biomed Environ Sci, 2014, 27(1): 3-9.
|
| [2] |
Mountain CF. Revisions in the international system for staging lung cancers[J]. Chest, 1997, 111(6): 1486-7. doi: 10.1378/chest.111.6.1486
|
| [3] |
Duffaud F, Therasse P. New guidelines to evaluate the response to treatment in solid tumors[J]. J Natl Cancer Inst, 2000, 87(12): 881-6.
|
| [4] |
James K, Eisenhauer E, Christian M, et al. Measuring response in solid tumors: unidimensional versus bidimensional measurement [J]. J Natl Cancer Inst, 1999, 91(6): 523-8. doi: 10.1093/jnci/91.6.523
|
| [5] |
Padhani AR, Ollivier L. Commentary - the RECIST criteria: implications for diagnostic radiologists[J]. Br J Radiol, 2001, 74 (887): 983-6. doi: 10.1259/bjr.74.887.740983
|
| [6] |
Hellomi M, Petralia G, Sonzogni A, et al. CT perfusion for the monitoring of neoadjuvant chemotherapy and radiation therapy in rectal carcinoma:initial experience[J]. Radiology, 2007, 244(2): 486-93. doi: 10.1148/radiol.2442061189
|
| [7] |
Ng QS, Goh V, Fichte H, et al. Lung cancer perfusion at multi-detector row CT: reproducibility of whole tumor quantitative measurements[J]. Radiology, 2006, 239(2): 547-53. doi: 10.1148/radiol.2392050568
|
| [8] |
Miles KA, Charnsangavej C, Lee FT, et al. Application of CT in the investigation of angiogenesis in oncology[J]. Acad Radiol, 2000, 7 (10): 840-50. doi: 10.1016/S1076-6332(00)80632-7
|
| [9] |
Lee TY, Purdie TG, Stewart E. CT imaging of angiogenesis[J]. Q J Nucl Med, 2003, 47(3): 171-87.
|
| [10] |
Wang GL, Zhang CQ, Li MY, et al. Preliminary application of High-Definition computed tomographic gemstone spectral imaging in lung cancer[J]. J Comput Assist Tomogr, 2014, 38(1): 77-81. doi: 10.1097/RCT.0b013e3182a21633
|
| [11] |
Mazzei MA, Guerrini S, Genovese EA, et al. Accuracy of multislice CT in restaging patients with non-small cell lung carcinoma after neoadjuvant chemotherapy using a multiparametric approach[J]. Recenti Prog Med, 2012, 103(11): 465-70.
|
| [12] |
Kamiyoshihara M, Kawashima O, Ishikawa S, et al. Mediastinal lymph node evaluation by computed tomographic scan in lung cancer[J]. J Cardiovasc Surg (Torino), 2001, 42(1): 119-24.
|
| [13] |
Shiau YC, Hsieh JF, Tsai SC, et al. Technetium-99m methoxy-isobutyl-isonitrile chest single photon emission computed tomography to detect mediastinal lymph node metastasis in patients with non-small cell lung cancer: comparison with computed tomography[J]. Anticancer Res, 2001, 20(5C): 3751-4. https://www.researchgate.net/publication/12065487_Technetium-99m_methoxy-isobutyl-isonitrile_chest_single_photon_emission_computed_tomography_to_detect_mediastinal_lymph_node_meastasis_in_patients_with_non-small_cell_lung_cancer_Comparison_with_compu
|
| [14] |
Knopp MV, Giesel FL, Marcos H, et al. Dynamic Contrast-Enhanced magnetic resonance imaging in oncology[J]. Top Magn Reson Imaging, 2001, 12(4): 301-8. doi: 10.1097/00002142-200108000-00006
|
| [15] |
Fujimoto K, Abe T, Muller NL, et al. Small peripheral pulmonary carcinomas evaluated with dynamic Mr imaging: correlation with tumor vascularity and prognosis[J]. Radiology, 2003, 227(3): 786-93. doi: 10.1148/radiol.2273020459
|
| [16] |
Stomper PC, Winston JS, Herman S, et al. Angiogenesis and dynamic Mr imaging Gadolinium enhancement of malignant and benign breast lesions[J]. Breast Cancer Res Treat, 1997, 45(1): 39-46. doi: 10.1023/A:1005897227030
|
| [17] |
Ohno Y, Nogami M, Higashino T, et al. Prognostic value of dynamic Mr imaging for non-small-cell lung Cancer patients after chemoradiotherapy[J]. J Magn Reson Imaging, 2005, 21(6): 775-83. doi: 10.1002/(ISSN)1522-2586
|
| [18] |
Philips TL. Radiation-chemotherapy interaction. Lung cancer principles and practice[J].Philadelphia:Lippincott-Raven.
|
| [19] |
Dean PB, Niemi P, Kivisaari L, et al. Comparative pharmacokinetics of Gadolinium DTPA and Gadolinium chloride [J]. Invest Radiol, 1988, 23(Suppl 1): S258-60. https://www.ncbi.nlm.nih.gov/pubmed/3198357
|
| [20] |
Franklin WA. Pathology of lung cancer[J]. J Thorac Imaging, 2000, 15(1): 3-12. doi: 10.1097/00005382-200001000-00003
|
| [21] |
Schaefer JF, Schneider V, Vollmar J, et al. Solitary pulmonary nodules: Association between signal characteristics in dynamic contrast enhanced MRI and tumor angiogenesis[J]. Lung Cancer, 2006, 53(1): 39-49. doi: 10.1016/j.lungcan.2006.03.010
|
| [22] |
Knopp MV, Weiss E, Sinn HP, et al. Pathophysiologic basis of contrast enhancement in breast tumors[J]. J Magn Reson Imaging, 1999, 10(3): 260-6. doi: 10.1002/(ISSN)1522-2586
|
| [23] |
Sommer G, Bauman G, Koenigkam-Santos M, et al. Non-contrast-enhanced preoperative assessment of lung perfusion in patients with non-small-cell lung Cancer using Fourier decomposition magnetic resonance imaging[J]. Eur J Radiol, 2013, 82(12): e879-87. doi: 10.1016/j.ejrad.2013.06.030
|
| [24] |
Henschke CI, Shaham D, Farooqi A, et al. Computerized tomography screening for lung Cancer: new findings and diagnostic work-up[J]. Kyobu Geka, 2003, 15(4): 397-404.
|
| [25] |
Bom HS, Yc K, Song HC, et al. Technetium 99mTc-MIBI uptake in small cell lung cancer[J]. Nucl Med, 1998, 39(1): 91-4.
|
| [26] |
Yoshihiri N, Yukiko K, Yuka Y, et al. 99mTC-MIBI and 201TI scintigraphy of primary lung cancer[J]. J Nucl Med, 1997, 38(9): 1358-61.
|
| [27] |
Hendrikse NH, Kuipers F, Meijer C, et al. In vivo imaging of hepatobiliary transport function mediated by multidrug resistance associated protein and P-glycoprotein cancer [J]. Chemother Phamacol, 2004, 54(2): 131-8. doi: 10.1007/s00280-004-0793-2
|
| [28] |
Kawai H, Kiura K, Tabata M, et al. Characterization of non-small-cell lung cancer cell lines established before and after chemotherapy[J]. Lung Cancer, 2002, 35(3): 305-14. doi: 10.1016/S0169-5002(01)00430-5
|
| [29] |
Nikoletic K, Lucic S, Peter A, et al. Lung 99mTc-MIBI scintigraphy: impact on diagnosis of solitary pulmonary nodule[J]. Bosn J Basic Med Sci, 2011, 11(3): 174-9.
|
| [30] |
Yang ST, Zhou YZ, Zeng J. 99mTc-MIBI single-photon emission-computed tomography in diagnosis of lung cancer and mediastinal metastasis lymph nodes[J]. Zhongguo Yao Li Xue Bao, 1999, 20(9): 800-4. https://www.ncbi.nlm.nih.gov/pubmed/11245087
|
| [31] |
Choi NC, Fischman AJ, Niemierko A, et al. Dose-response relationship between probability of pathologic tumor control and glucose metabolic rate measured with FDG PET after preoperative chemoradiotherapy in locally advanced non-small-cell lung cancer [J]. Int J Radiat Oncol Biol Phys, 2002, 54(4): 1024-35. doi: 10.1016/S0360-3016(02)03038-9
|
| [32] |
Cerfolio RJ, Bryant AS, Winokur TS, et al. Repeat FDG-PET after neoadjuvant therapy is a predictor of pathologic response in patients with non-small cell lung cancer[J]. Ann Thorac Surg, 2004, 78(6): 1903-9; discussion 1909. doi: 10.1016/j.athoracsur.2004.06.102
|
| [33] |
Kumar A, Kumar R, Seenu V, et al. The role of 18F-FDG PET/CT in evaluation of early response to neoadjuvant chemotherapy in patients with locally advanced breast cancer[J]. Eur Radiol, 2009, 19(6): 1347-57. doi: 10.1007/s00330-009-1303-z
|
| [34] |
Cerfolio RJ, Bryant AS, Ojha B. Restaging patients with N2(stage IIIa)non-small cell lung cancer after neoadjuvant chemo-radiotherapy.a prospective study[J]. J Thorac Cardiovasc Surg, 2006, 131(6): 1229-35. doi: 10.1016/j.jtcvs.2005.08.070
|
| [35] |
Pöttgen C, Levegrün S, Theegarten D, et al. Value of 18F-fluoro-2-deoxy-D-glucose-positron emission tomography/ computed tomography in non-small-cell lung cancer for prediction of pathologic response and times to relapse after neoadjuvant chemoradiotherapy[J]. Clin Cancer Res, 2006, 12(1): 97-106. doi: 10.1158/1078-0432.CCR-05-0510
|
| [36] |
Rozental JM, Levine RL, Nickles RJ, et al. Glucose-uptake by gliomas after treatment - a positron emission tomographic study[J]. Arch Neurol, 1989, 46(12): 1302-7. doi: 10.1001/archneur.1989.00520480044018
|
| [37] |
De Witte O, Hildebrand J, Luxen A. et al. Acute effect of camus-tine glucose metabolism in brain and glioblastoma[J]. Cancer, 1994, 74 (10): 2836-42. doi: 10.1002/(ISSN)1097-0142
|
| [38] |
Shankar LK, Hoffman M, Bacharach S, et al. Consensus recommendations for use of 18F-FDG PET as an indicator off therapeutic response in patients in National cancer Institute Trials [J]. J Nucl Med, 2006, 47(6): 1059-66.
|
| [39] |
Kanters LV, biologicalfactors in the prognosis of non-small cell lung cancer Eur Respira J 11, 0laussen K A DA, et al. DNA repair by ERCC1 in non-small-cell-cancer lung cancer and cisplatin-based adjuvant chemotherapy[J]. N Eng1 J Med, 2006, 355(10): 983-91. doi: 10.1056/NEJMoa060570
|
| [40] |
Niedemhofer LJ, Odijk H, Budzowska M, et al. The structure specific endonuclease Erccl-X pf is required to resolve DNAinterstrand cross-link-induced double-strand breaks [J]. Mo1CellBiol, 2004, 24(13): 5776-87.
|
| [41] |
Suk R, Gurubhagavatula S, Park S, et al. Polymorphisms in ERCC1 and grade 3 or 4 toxicity in non-small cell lung cancer patients[J]. Clinical Cancer Research, 2005, 11(4): 1534-8. doi: 10.1158/1078-0432.CCR-04-1953
|
| [42] |
Harada T, Ogura S, Yamazaki K, et al. Predictive value of expression of P53, Bcl-2 and lung resistance-related protein for response to chemotherapy in non-small cell lung cancers[J]. Cancer Sci, 2003, 94(4): 394-9. doi: 10.1111/cas.2003.94.issue-4
|
| [43] |
Krajewska M, Turner BC, Shabaik A, et al. Expression of BAG-1 protein correlates with aggressive behavior of prostate cancers[J]. Prostate, 2006, 66(8): 801-10. doi: 10.1002/(ISSN)1097-0045
|
| [44] |
Crocoll A, Schneikert J, Hubner S, et al. BAG-1M: A potential specificity determinant of corticosteroid receptor action[J]. Kidney Int, 2000, 57(4): 1265-9. doi: 10.1046/j.1523-1755.2000.00960.x
|
| [45] |
Boar RH, Smith IE, Pastorino U, et al. Pre-operative chemotherapy in early stage resectable non-small-cell lung Cancer:a Smith 11,, Pastorino U.et al.Pre-operative randomized feasibility study justifying a multicentre phase III trial[J]. Br J Cancer, 1999, 79(9/ 10): 1514-8. doi: 10.1038/sj.bjc.6690241
|
| [46] |
Junker KF. Grading of tumor regression in nor-small cell lung cancers[J]. Chest, 2001, 120(5): 1584-91. doi: 10.1378/chest.120.5.1584
|
| [47] |
Rastogi P, Anderson SJ, Bear HD, et al. Preoperative chemotherapy: updates of National surgical adjuvant breast and bowel project protocols B-18 and B-27[J]. J Clin Oncol, 2008, 26(5): 778-85. doi: 10.1200/JCO.2007.15.0235
|
点击查看大图
下载:
